ArtVentive announces $10,000,000 USD agreement with European financial group ArtVentive Medical Group, Inc where to buy in uk . Announced today a ten million dollar financing contract with a European monetary group. A company commitment for the initial tranche of $1,950,000 is at $.90 per share with the remainder of the financing to cost at no less than $.90 per share. The pricing will be linked with the current selling price when drawn down by the Company then. The financing will end up being dedicated to clinical trials and regulatory approvals, to commercialization in European countries and North America prior, with Eastern Europe, Japan, Asia Latin and Pacific America following.
In October of 2007, Arteriocyte partnered with DW Healthcare Companions and Comerica to create Arteriocyte Medical Systems Inc., in order to commercialize and distribute novel medical gadgets and point of treatment surgical solutions to improve patient outcomes. Arteriocyte Medical Systems includes a strategic partnership with Medtronic which includes a worldwide exclusive distribution agreement for Arteriocyte Medical System’s Magellan Autologous platelet separation gadget by Medronic’s Cardiac Medical procedures division. Today The Magellan system is used in over 400 surgical centers worldwide.. Arteriocyte awarded DARPA financing for company’s bloodstream pharming technology Arteriocyte announced today a $1,950,000 award from DARPA for the business’s Nanofiber Based System technology for the Creation of Red Bloodstream Cells project.